1. Tositumomab (Bexxar®) BLA 125011 Medical Review FDA, June 2003
2. Tositumomab (Bexxar®) BLA 125011/S024 Medical Review Dec 2004
3. Tositumomab (Bexxar®) Product Monograph GSK, Canada Dec 2007
4. Tositumomab (Bexxar®) Prescribing Information GSK, Aug 2012
5. Boross P, Leusen JHW (2012) Mechanisms of action of anti CD20 antibodies. Am J Cancer Res 2:676–690